Moreover, studies with proliferative vitreoretinopathy (PVR) patients have shown increased levels of PEDF in the vitreous (175), suggesting that PEDF may act through a positive regulatory feedback loop to counteract the angiogenic response and inhibit the activity of fibrotic factors. This evidence concerns the gene SERPINF1 and CAPN5-related vitreoretinopathy.